This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Wall Street Veteran Barbara Ryan Joins FTI Consulting

WEST PALM BEACH, Fla., April 2, 2013 /PRNewswire/ -- FTI Consulting, Inc. (NYSE: FCN), the global business advisory firm dedicated to helping organizations protect and enhance their enterprise value, today announced that Barbara Ryan has been appointed Managing Director in the firm's Strategic Communications practice. 

The addition of Ms. Ryan, a recognized biopharmaceutical industry expert and veteran Wall Street professional, further strengthens the practice's financial communications capabilities and deepens its expertise in the healthcare and life sciences sector. In her new role, Ms. Ryan will also support the firm's healthcare and life sciences transactions communications and crisis communications offerings. She will be based in New York. 

Ms. Ryan brings more than 30 years of Wall Street experience and financial expertise, with a focus in the biopharmaceutical sector, to FTI Consulting. She joins the firm from Deutsche Bank, where she held the position of Managing Director and Head of the Pharmaceutical Research Team for the past 20 years. In this role, Ms. Ryan published pharmaceutical research, led the firm's annual healthcare conference and conducted extensive marketing activities with institutional clients. She also served as the lead analyst on several high-profile initial public offerings. Prior to joining Deutsche Bank, Ms. Ryan held pharmaceutical analyst positions at Prudential Securities and Bear Sterns. Ms. Ryan frequently is a guest contributor to CNBC.

"Barbara is an exciting addition to our thriving healthcare and life sciences sector," said Edward Reilly, Global Chief Executive Officer of the FTI Consulting Strategic Communications practice. "Barbara is a well-known and well-respected voice in the healthcare industry with a deep understanding of how investors think about and value stocks. Our clients will undoubtedly benefit from her valuable perspective and insight as they face critical times of corporate growth and transformation."

Ms. Ryan added, "FTI Consulting is a clear leader in healthcare strategic communications, and I am excited to join such a dynamic and growing practice. I look forward to utilizing my many years of experience on Wall Street covering the pharmaceutical industry to further advance the firm's healthcare and life sciences capital markets offering."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.27 -0.76%
FB $101.00 1.47%
GOOG $684.12 0.89%
TSLA $143.67 -3.09%
YHOO $27.10 1.04%


Chart of I:DJI
DOW 15,914.74 -99.64 -0.62%
S&P 500 1,851.86 -0.35 -0.02%
NASDAQ 4,283.5920 +14.8290 0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs